EQO Inc. provides water monitoring and treatment services aimed at mitigating the impact of aquatic invasive species, particularly zebra mussels. Using technologies originally developed for microbiome analytics and early cancer detection, EQO offers the earliest possible detection combined with high granularity quantitation of infestation and potential for infestation. The firm monitors critical points of infrastructure and vectors of infestation utilizing an automated collection and preservation system that can be semi-permanently installed; it also offers single-use collection and preservation kits. Mitigation is achieved by determining live versus dead, population activity, life cycle, and response to treatment, as well as treatment optimization through a combination of services. Eradication is an active area of research for EQO: it is actively pursuing the development of a smart drug approach to zebra and quagga mussel eradication. The goal of this project is the creation of a cost efficient, environmentally responsible, low risk product capable of full eradication without negatively impacting the native ecosystem.
